Eton Pharmaceuticals (ETON) Receivables - Other (2022)
Eton Pharmaceuticals' (ETON) quarterly Receivables - Other came in at $250000.0 in Q3 2022, little changed quarter-over-quarter from $250000.0 in Q2 2022.
Powered by 
Analysis
Eton Pharmaceuticals (ETON) Receivables - Other (2022) Analysis & Trends
Eton Pharmaceuticals has disclosed Receivables - Other across 1 years of filings, most recently posting $250000.0 for Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Eton Pharmaceuticals | 1.63 Bn | 1.60 Bn | 25.41 Mn |